Bellerophon Therapeutics, Inc.·4

Feb 23, 9:39 PM ET

Bellerophon Therapeutics, Inc. 4

4 · Bellerophon Therapeutics, Inc. · Filed Feb 23, 2015

Insider Transaction Report

Form 4
Period: 2015-02-19
MEGLASSON MARTIN
Chief Scientific Officer
Transactions
  • Purchase

    Common Stock

    2015-02-19$12.00/sh+12,000$144,00018,386 total

Documents

1 file
  • 4
    a4.xmlPrimary

    4